Dr. Herman Jay Herman, M.D.

Contact Dr. Herman

111 S. 11th Street
Suite 8220, Gibbon Building
Philadelphia, PA 19107

(215) 955-8244
(215) 923-3836 fax

Research and Clinical Interests
Dr. Herman's research interests have been focused in the fields of platelet transfusion practice, pediatric transfusion, platelet and neutrophil immune disorders, blood stem cell collection and new apheresis technology. His clinical interests have focused on laboratory management, immunohematologic disorders and non-malignant hematologic diseases of children and adults, especially platelet disorders.

Publications

Most recent Peer-reviewed Publications

  1. In Reply
  2. Prevention of D sensitization after mismatched transfusion of blood components: Toward optimal use of RhIG
  3. Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity
  4. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation
  5. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation
  6. Acute hypertensive transfusion reactions
  7. Alternative explanation for "muddy plasma" [3]
  8. Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: Case report and review of the literature
  9. Apheresis platelet transfusions: Does ABO matter?
  10. Platelet dosing
  11. Single-donor platelets reduce the risk of septic platelet transfusion reactions.
  12. Early prediction of poor hematopoietic progenitor cell (HPC) mobilization
  13. Severe cutaneous ulceration following treatment with thalidomide for GVHD
  14. Economic consequences of alterations in platelet transfusion dose: Analysis of a prospective, randomized, double-blind trial
  15. Considerations in the selection of a platelet component: Apheresis versus whole blood-derived
  16. Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial
  17. Metabolic consequences in very low birth weight infants transfused with older AS-1-preserved erythrocytes
  18. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator
  19. Platelet transfusion: A review of key concepts
  20. Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT

View All Publications